If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

 

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Health Regulatory News (PHC)

Share Price Information for Plant Health (PHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.41
Bid: 4.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.70 (17.50%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 4.41
PHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Technology Update

28 Nov 2018 07:00

RNS Number : 6896I
Plant Health Care PLC
28 November 2018
 

28 November 2018

 

PLANT HEALTH CARE plc

 

 

("Plant Health Care" or the "Company")

 

 

New Technology Update 

 

 

Plant Health Care®, a leading provider of novel patent-protected biological products to global agriculture markets, is pleased to provide the following update in relation to its New Technology business in corn and soy crops.

 

Highlights:

- Plant Health Care's novel PREtec (Plant Response Elicitor Technology) has very large potential in the more than 375 million acres of corn and soy planted in North America, Brazil and Argentina.

- Three more global agricultural/seed companies have signed agreements to evaluate Plant Health Care's PREtec product candidates on multiple crops on three continents.

- These new collaborators are seeking novel, low toxicity biological products such as PREtec, to enable farmers to be more productive with lower environmental impact.

- Plant Health Care is continuing field trials with the Company's Innatus 3G peptide PHC279 against Asian Soybean Rust (ASR) in Brazil.

 

PREtec is a novel, environmentally friendly approach to protecting crops, based on peptides derived from natural proteins. These proprietary peptides are stable and compatible with mainstream agriculture practices. By activating the innate growth and defence mechanisms of plants, PREtec peptides lead to higher crop yields and better protection against disease and environmental stresses such as drought.

 

Corn and soy are major targets for PREtec. They are grown on more than 375 million acres in North and South America. A yield increase of just 2% brings a soybean farmer in Brazil almost an additional $10 per acre; in the USA it brings a corn (maize) farmer almost $13 per acre. Plant Health Care's evaluation partners supply most of the leading corn and soy seed treatments.

 

PREtec peptides can also reduce the corn yield losses caused by drought stress during critical growth stages. Under the drought conditions of the Company's field trials, corn plants whose seeds were treated with PREtec increased yield by an average of almost 17% over three consecutive growing seasons compared to untreated plants.

 

Three additional global agricultural companies have now signed agreements to evaluate several platforms of the PREtec technology. These companies join existing evaluation partners, who are looking for novel technology that will boost yield in row crops and have a safe environmental profile while solving significant problems faced by growers today.

 

In the 2018/19 soybean growing season in Brazil, Plant Health Care will be conducting further trials of PHC279 against Asian Soybean Rust (ASR). Last season this product did not deliver a decisive impact on disease symptoms as a foliar spray, but did show yield improvements. This season, trials will assess the economic value of PHC279 seed treatment and early season sprays.

 

Chris Richards, Executive Chairman & Interim CEO, said "As we continue to generate positive results from our PREtec platform of peptides, we are delighted to expand our range of partners who will evaluate our technology on multiple crops in multiple regions during the 2019 growing season."

 

For further information, please contact:

 

Plant Health Care plc

 

Chris Richards, Executive Chairman and Interim CEO

 

Tel: +1 919 926 1600

Arden Partners plc (Nomad and Broker)

John Llewellyn-Lloyd

 

Dan Gee-Summons

Tel: +44 (0) 20 7614 5900

 

IFC Advisory (Financial PR)

 

Graham Herring

 

Miles Nolan

 

Zach Cohen

Tel: +44 (0) 20 3934 6630

 

 

 

Company website: www.planthealthcare.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDPGGCGGUPRGBM
Date   Source Headline
12th Apr 20061:30 pmRNSDirector/PDMR Shareholding
10th Apr 20067:02 amRNSSecondary Placing
10th Apr 20067:02 amRNSFinal Results
13th Mar 20067:01 amRNSMyconate - test results
6th Mar 20064:01 pmRNSAppt of Finance Director
25th Jan 20067:01 amRNSTrading Update
15th Dec 20057:00 amRNSMyconate Test Results
3rd Nov 20057:00 amRNSResearch Agreement
20th Sep 200510:56 amRNSDirectors' Holdings
19th Sep 20057:02 amRNSLicensing Agreement
19th Sep 20057:01 amRNSInterim Results
12th Sep 20059:01 amRNSNotice of Results
30th Aug 20057:03 amRNSContract Win
15th Aug 20051:49 pmRNSHolding(s) in Company
4th Aug 20057:00 amRNSNew Product Launch
22nd Jul 20057:00 amRNSDirectorate Change
18th Jul 200510:25 amRNSHolding(s) in Company
4th Jul 20051:24 pmRNSCoSec Change & Share Listing
24th Jun 20053:54 pmRNSDirector Shareholding
13th Jun 20057:01 amRNSDirector Shareholding
10th Jun 200512:51 pmRNSAGM Statement
1st Jun 20057:02 amRNSNew Partnership Initiative
29th Apr 20055:05 pmRNSDirector Shareholding
26th Apr 20057:01 amRNSFinal Results
13th Apr 20057:00 amRNSNew Contract
21st Mar 20053:59 pmRNSDirector Shareholding
7th Mar 20057:02 amRNSTrading Statement
31st Jan 20057:04 amRNSPHC wins tree care trial

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.